title: Transglutaminase-1 gene mutations in autosomal recessive congenital ichthyosis: summary of mutations (including 23 novel) and modeling of TGase-1.
abstract: Autosomal recessive congenital ichthyosis (ARCI) is a heterogeneous group of rare cornification diseases. Germline mutations in TGM1 are the most common cause of ARCI in the United States. TGM1 encodes for the TGase-1 enzyme that functions in the formation of the cornified cell envelope. Structurally defective or attenuated cornified cell envelop have been shown in epidermal scales and appendages of ARCI patients with TGM1 mutations. We review the clinical manifestations as well as the molecular genetics of ARCI. In addition, we characterized 115 TGM1 mutations reported in 234 patients from diverse racial and ethnic backgrounds (Caucasion Americans, Norwegians, Swedish, Finnish, German, Swiss, French, Italian, Dutch, Portuguese, Hispanics, Iranian, Tunisian, Moroccan, Egyptian, Afghani, Hungarian, African Americans, Korean, Japanese and South African). We report 23 novel mutations: 71 (62%) missense; 20 (17%) nonsense; 9 (8%) deletion; 8 (7%) splice-site, and 7 (6%) insertion. The c.877-2A>G was the most commonly reported TGM1 mutation accounting for 34% (147 of 435) of all TGM1 mutant alleles reported to date. It had been shown that this mutation is common among North American and Norwegian patients due to a founder effect. Thirty-one percent (36 of 115) of all mutations and 41% (29 of 71) of missense mutations occurred in arginine residues in TGase-1. Forty-nine percent (35 of 71) of missense mutations were within CpG dinucleotides, and 74% (26/35) of these mutations were C>T or G>A transitions. We constructed a model of human TGase-1 and showed that all mutated arginines that reside in the two beta-barrel domains and two (R142 and R143) in the beta-sandwich are located at domain interfaces. In conclusion, this study expands the TGM1 mutation spectrum and summarizes the current knowledge of TGM1 mutations. The high frequency of mutated arginine codons in TGM1 may be due to the deamination of 5' methylated CpG dinucleotides.
authors.affiliation: Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland 20892-4562, USA.
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Herman
authors.forename: Sharifeh
authors.initials: S
authors.lastname: Farasat
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Steinbach
authors.forename: Ming-Hui
authors.initials: MH
authors.lastname: Wei
authors.forename: Ousmane
authors.initials: O
authors.lastname: Toure
authors.forename: Philip
authors.initials: P
authors.lastname: Fleckman
authors.forename: Patrick
authors.initials: P
authors.lastname: Blake
authors.forename: Sherri J
authors.initials: SJ
authors.lastname: Bale
authors.forename: Jorge R
authors.initials: JR
authors.lastname: Toro
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D005808:Genes, Recessive; D006801:Humans; D016113:Ichthyosiform Erythroderma, Congenital / Q000235:genetics* / Q000473:pathology; D008958:Models, Molecular; D009154:Mutation; D011110:Polymorphism, Genetic; D017434:Protein Structure, Tertiary; D011503:Transglutaminases / Q000737:chemistry / Q000235:genetics*
chemical_list: D011503:Transglutaminases; C105804:transglutaminase 1